Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. - Wikidata - awgldk - TriplyDB

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

http://www.wikidata.org/entity/Q38098473

about

Abnormal movements in critical care patients with brain injury: a diagnostic approach Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature Neuropsychiatric lupus: a mosaic of clinical presentations Current treatment of antiphospholipid syndrome: lights and shadows.An update on tardive dyskinesia: from phenomenology to treatment Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.Chorea, a little-known manifestation in systemic lupus erythematosus: short literature review and four case reports.Neurology of rheumatologic disorders.Chorea associated with Huntington's disease: to treat or not to treat?Identification and management of tardive dyskinesia: A case series and literature review.Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.Brain SPECT in Sydenham's chorea in remission.Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.Diurnal Salivary Cortisol and Regression Status in MECP2 Duplication Syndrome.Jaw Dystonia and Reversible Basal Ganglia Changes as an Initial Presentation of Systemic Lupus Erythematosus.Treatment options for chorea.Reversible chorea and parkinsonism in a patient with systemic lupus erythematosus.Neuropsychiatric Lupus in clinical practice.Neurological Disease in Lupus: Toward a Personalized Medicine Approach.

P2860

Q26765818-3888D7F1-AAA4-42EE-AB7D-6F6496E91655 Q26801152-4C42C9BD-56FF-440F-8C50-C2D406E5CF81 Q27027588-3D234E4F-BBE7-4C17-85F3-432AF336164A Q33423959-C53E1FE0-FB4B-4FEA-B574-B0B9ED56052A Q37006021-0F132C01-55E6-45B6-9B9C-99E97444A0B5 Q37704593-DE4170C2-5769-4476-B481-A6291BDCD251 Q38153171-41585851-AB53-4113-9908-1E3174B9E26F Q38215698-F886DB90-E5AF-41C7-AE0B-255CAD0B9729 Q38243296-C2273A9D-A431-477A-9F10-B7C8B816DBE8 Q38555637-FE874FA4-FF9F-48A2-9ACC-3D73AD242ED9 Q39423412-C500A1D6-8699-4FF4-9F08-7164C1A016EC Q40215907-77090D9F-3A84-4EF1-9CC4-C78AA28A0171 Q40751109-603A3126-8057-4BEA-BD8B-E3A4638C8140 Q41208234-60B85A31-14D6-4902-8936-3BEE4B9D3A04 Q47896606-DFFA48AA-871E-4CB2-9113-6A3C36FD347F Q47977953-E7A9FA36-7BFC-410D-8E1C-CF2030B8912D Q49119753-E8A49D1C-D34B-4EA4-B4F7-DF83A81C2BF6 Q51251394-72F50156-4DA8-426F-BF0C-29FDB5C960B6 Q55267080-176AE36A-148C-4329-8BA3-554D885EBE15

P2860

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

http://www.wikidata.org/entity/Q38098473

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

@en

type

label

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

@en

prefLabel

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

@en

P1433

Q38098473-C31DFE14-0275-4B7F-AF41-4A434278E845

P1476

Q38098473-D5E4C635-3136-4CD5-BBD7-9AF055D5BE36

P2093

Q38098473-4DD6CDCF-C392-41EF-9964-B24898483C44

Q38098473-CF4AFE51-FB28-4219-885A-4DDB703AC65F

P2860

Q38098473-07A6B50D-6EF4-4DC9-999B-6D3B8020FA6F

Q38098473-0817DFA9-63AE-4FE3-ACC5-456900377C5F

Q38098473-0FF7F7D3-0760-463C-BE02-C9C745089E2A

Q38098473-107AE52B-39F2-45E6-B0BE-D97088FF44BA

Q38098473-11FD13A4-DB5F-4AA1-BF9B-A77812CA3810

Q38098473-170F08C5-FB5E-42BE-9724-21BCE7D1464C

Q38098473-19B1E80A-6751-4656-B879-33C1D2749463

Q38098473-1C40ED8E-6D00-43A2-990E-7D2A08603DF9

Q38098473-1FA07577-301E-4D54-AA77-01DA7BB7CF34

Q38098473-28E2682A-2E11-46CD-AD96-F9DADBC4E288

P2888

Q38098473-9ECBC113-1F7F-48EC-B7B9-6BE6899EE144

P304

Q38098473-04168EAA-5379-42CE-8478-03CAE11AC06C

P31

Q38098473-18B88B76-FEC0-414C-82A5-DB3178D89F6A

P356

Q38098473-B5CFEC2C-EFE9-41CE-A7D1-3A858B4D269F

P433

Q38098473-E3ED96F2-CC6A-4C37-8B22-9C1DA3F6E695

P478

Q38098473-AA771739-0F6D-4A34-94E4-A17572B6C649

P50

Q38098473-68AF215C-31D9-4920-9498-EB3C550DFA15

P577

Q38098473-C5BA2307-3871-42B7-9DE7-56604925BBBB

P5875

Q38098473-01E0C919-6D0C-4F6F-877A-E7475E37CE8D

P698

Q38098473-6D3DF1EC-8047-4630-AF30-485C726D16E1

P356

S00702-013-1023-Z

P1433

Journal of Neural Transmission

P1476

Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

@en

P2093

Cecilia Bonnet

http://www.w3.org/2001/XMLSchema#string

José Fidel Baizabal-Carvallo

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Clinical spectrum of voltage-gated potassium channel autoimmunity

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

The 1982 revised criteria for the classification of systemic lupus erythematosus

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Systemic lupus erythematosus presenting with steroid-responsive parkinsonism and post-hemiplegic dystonia.

Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood.

Antiphospholipid syndrome and dystonia-parkinsonism. A case report.

Hyperactivity in a mouse model of the antiphospholipid syndrome.

Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

P2888

s00702-013-1023-z

P304

1579-1589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-013-1023-Z

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Jankovic

P577

2013-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236196666

http://www.w3.org/2001/XMLSchema#string

P698

23580159

http://www.w3.org/2001/XMLSchema#string